American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

Enanta Pharmaceuticals, Inc

ENTA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

ENTA historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of ENTA by members of U.S. Congress

Politician Type Traded
Daniel S. Goldman House / D Sale $1,001 - $15,000 Jul 12, 2023
Thomas MacArthur House / R Sale $1,001 - $15,000 May 27, 2015
Thomas MacArthur House / R Purchase $1,001 - $15,000 Mar 20, 2015
ENTA Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ENTA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ENTA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in ENTA holdings by institutional investors

Insider Trading

Quarterly net insider trading by ENTA's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $20,000 Nov 14, 2023 Issue: Health Issues
Revolving Door

Former government officials who have lobbied for ENTA

Quiver Logo

No former government officials on record as having lobbied for ENTA

Revolving Door Dashboard
Corporate Lobbying

ENTA Estimated quarterly lobbying spending

Revenue Breakdown

ENTA Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ENTA Income Statement
ENTA Balance Sheet
ENTA Cash Flow
U.S. Patents

New ENTA patent grants

  • Patent Title: Benzodiazepine derivatives as rsv inhibitors May. 01, 2018
  • Patent Title: Benzimidazole derivatives Sep. 19, 2017
  • Patent Title: Nucleoside and nucleotide derivatives Aug. 15, 2017
  • Patent Title: Deuterated nucleoside/tide derivatives Aug. 01, 2017
  • Patent Title: Hepatitis c virus inhibitors Jun. 13, 2017
  • Patent Title: Nucleoside and nucleotide derivatives Jun. 13, 2017
  • Patent Title: Cyclosporin analogues for preventing or treating hepatitis c infection Jun. 06, 2017
  • Patent Title: Cyclosporin analogues for preventing or treating hepatitis c infection Apr. 11, 2017
  • Patent Title: Cyclosporin analogues for preventing or treating hepatitis c infection Mar. 28, 2017
  • Patent Title: Macrocylic oximyl hepatitis c protease inhibitors Dec. 27, 2016
  • Patent Title: Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives Jan. 26, 2016
  • Patent Title: Cyclosporin analogues for preventing or treating hepatitis c infection Dec. 29, 2015
  • Patent Title: Macrocyclic proline derived hcv serine protease inhibitors Dec. 29, 2015
  • Patent Title: Bismacrocyclic compounds as hepatitis c virus inhibitors Nov. 24, 2015
  • Patent Title: Cyclosporin analogues for preventing or treating hepatitis c infection Oct. 13, 2015
  • Patent Title: Hepatitis c virus inhibitors Oct. 13, 2015
  • Patent Title: Hepatitis c virus inhibitors Sep. 08, 2015
  • Patent Title: 2′allene-substituted nucleoside derivatives Jul. 21, 2015
  • Patent Title: Combination pharmaceutical agents as inhibitors of hcv replication Jun. 23, 2015
  • Patent Title: Linked dibenzimidazole antivirals Apr. 07, 2015
  • Patent Title: Quinoxalinyl derivatives Feb. 24, 2015
  • Patent Title: Quinoxaline-containing compounds as hepatitis c virus inhibitors Feb. 10, 2015
  • Patent Title: Fluorinated tripeptide hcv serine protease inhibitors Jan. 27, 2015
  • Patent Title: Macrocyclic compounds as hepatitis c virus inhibitors Jan. 20, 2015
  • Patent Title: Hepatitis c virus inhibitors Jan. 13, 2015
  • Patent Title: Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives Jan. 06, 2015
  • Patent Title: Hepatitis c virus inhibitors Jan. 06, 2015
  • Patent Title: Processes for the preparation of novel benzimidazole derivatives Dec. 30, 2014
  • Patent Title: [n-me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis c infection Dec. 09, 2014
  • Patent Title: Macrocyclic nucleoside phosphoramidate derivatives Sep. 30, 2014
  • Patent Title: Hepatitis c virus inhibitors Sep. 02, 2014
  • Patent Title: Hepatitis c virus inhibitors Aug. 26, 2014
  • Patent Title: Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors Aug. 19, 2014
  • Patent Title: Hepatitis c virus inhibitors Jul. 22, 2014
  • Patent Title: Tetrazolyl macrocyclic hepatitis c serine protease inhibitors Jul. 22, 2014
  • Patent Title: Hepatitis c virus inhibitors Jul. 15, 2014
  • Patent Title: Hepatitis c virus inhibitors Jun. 24, 2014
  • Patent Title: Hepatitis c virus inhibitors Apr. 22, 2014
  • Patent Title: Hepatitis c virus inhibitors Apr. 15, 2014
  • Patent Title: Cyclosporin analogues Apr. 01, 2014
  • Patent Title: Benzimidazole derivatives Mar. 18, 2014
  • Patent Title: Hepatitis c virus inhibitors Feb. 18, 2014
  • Patent Title: Macrocyclic proline derived hcv serine protease inhibitors Feb. 11, 2014
  • Patent Title: Linked diimidazole derivatives Jan. 28, 2014
  • Patent Title: Antiviral agents Jan. 07, 2014
  • Patent Title: Hepatitis c virus inhibitors Dec. 17, 2013
  • Patent Title: 2′-chloroacetylenyl substituted nucleoside derivatives Nov. 05, 2013
  • Patent Title: Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives Oct. 08, 2013
  • Patent Title: Hepatitis c virus inhibitors Aug. 13, 2013
  • Patent Title: Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors May. 17, 2011
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to ENTA from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ENTA News

Recent insights relating to ENTA

CNBC Recommendations

Recent picks made for ENTA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ENTA

ENTA Analyst Ratings

ENTA Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ENTA Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ENTA stock a Buy, Sell, or Hold?

  • What is the price target for $ENTA stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ENTA Top Shareholders
Shareholder
Shares Held
ENTA Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ENTA stock?

  • Who owns the most shares of $ENTA stock?

  • What funds own $ENTA stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ENTA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ENTA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ENTA

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

  • Address Watertown, MA
  • Market Cap 349.5 million
  • Employees 120
  • Industrial Classification Pharmaceutical Preparations

Enanta Pharmaceuticals, Inc (ENTA) Historical Stock Prices

Enanta Pharmaceuticals, Inc (ENTA) closed at $12.00 on September 24, 2026. Over the past year its adjusted close ranged from $7.75 to $16.85. Daily prices go back to January 2, 2014, 3,201 trading days in all.

  • 1 month-14.77%
  • 3 months-10.78%
  • Year to date-23.91%
  • 1 year+53.65%
  • 3 years+8.21%
  • 5 years-78.57%
  • Max-57.57%
See every congressional and insider trade on the ENTA price chart

Quiver Premium charts ENTA's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 11.94 12.02 11.67 12.00 12.00 206,240
Sep 23, 2026 12.33 12.33 11.87 11.95 11.95 206,321
Sep 22, 2026 12.24 12.47 12.03 12.42 12.42 164,646
Sep 21, 2026 12.28 12.28 11.94 12.11 12.11 217,213
Sep 18, 2026 12.49 12.61 12.19 12.20 12.20 428,245
Sep 17, 2026 12.67 12.84 12.48 12.52 12.52 277,682
Sep 16, 2026 12.33 12.92 12.33 12.70 12.70 267,530
Sep 15, 2026 13.07 13.07 12.16 12.29 12.29 284,879
Sep 14, 2026 12.81 13.13 12.79 13.12 13.12 280,241
Sep 11, 2026 12.83 13.04 12.59 12.96 12.96 289,137
Sep 10, 2026 13.09 13.21 12.44 12.70 12.70 312,792
Sep 9, 2026 13.50 13.51 13.09 13.24 13.24 192,952
Sep 8, 2026 13.91 13.91 13.43 13.50 13.50 158,196
Sep 4, 2026 13.92 14.22 13.45 14.08 14.08 233,450
Sep 3, 2026 14.17 14.29 13.85 14.02 14.02 239,350
Sep 2, 2026 13.56 14.19 13.48 14.09 14.09 251,783
Sep 1, 2026 13.34 13.64 13.24 13.51 13.51 217,295
Aug 31, 2026 13.52 13.60 13.12 13.33 13.33 286,516
Aug 28, 2026 13.72 13.91 13.47 13.60 13.60 155,915
Aug 27, 2026 14.08 14.18 13.76 13.80 13.80 280,234
Aug 26, 2026 14.00 14.37 13.75 14.15 14.15 156,203
Aug 25, 2026 14.06 15.05 14.02 14.08 14.08 407,078
Aug 24, 2026 13.44 14.27 12.83 14.10 14.10 357,439
Aug 21, 2026 13.27 13.70 13.09 13.47 13.47 335,246
Aug 20, 2026 13.42 13.50 12.93 13.13 13.13 194,821
Aug 19, 2026 13.51 13.63 13.16 13.51 13.51 187,392
Aug 18, 2026 12.80 13.42 12.80 13.30 13.30 196,630
Aug 17, 2026 13.13 13.32 12.59 12.83 12.83 314,792
Aug 14, 2026 13.38 13.39 12.96 13.16 13.16 173,405
Aug 13, 2026 13.57 13.98 13.44 13.44 13.44 152,715
Aug 12, 2026 13.48 13.68 13.27 13.50 13.50 149,824
Aug 11, 2026 13.74 13.82 12.71 13.52 13.52 200,170
Aug 10, 2026 13.73 13.86 13.64 13.81 13.81 147,586
Aug 7, 2026 13.43 13.87 13.35 13.77 13.77 182,991
Aug 6, 2026 13.27 13.54 13.19 13.34 13.34 220,703
Aug 5, 2026 13.40 13.68 13.03 13.22 13.22 230,044
Aug 4, 2026 13.05 13.63 12.71 13.32 13.32 209,591
Aug 3, 2026 12.70 12.97 12.34 12.95 12.95 168,147
Jul 31, 2026 12.73 12.99 12.50 12.60 12.60 143,719
Jul 30, 2026 12.42 13.02 12.32 13.00 13.00 142,363
Jul 29, 2026 12.56 12.73 12.37 12.45 12.45 147,298
Jul 28, 2026 12.76 12.76 12.40 12.61 12.61 177,279
Jul 27, 2026 12.96 13.16 12.66 12.73 12.73 91,837
Jul 24, 2026 13.06 13.06 12.41 12.78 12.78 104,646
Jul 23, 2026 12.87 13.09 12.52 12.95 12.95 129,270
Jul 22, 2026 13.36 13.81 13.01 13.06 13.06 153,950
Jul 21, 2026 13.15 13.65 12.90 13.42 13.42 159,594
Jul 20, 2026 13.99 13.99 12.98 13.16 13.16 169,213
Jul 17, 2026 13.04 13.85 13.04 13.74 13.74 189,866
Jul 16, 2026 13.23 13.56 12.94 13.19 13.19 160,366
Jul 15, 2026 13.07 13.39 12.80 13.23 13.23 101,202
Jul 14, 2026 13.64 13.75 13.10 13.11 13.11 136,868
Jul 13, 2026 13.60 13.97 13.43 13.64 13.64 139,402
Jul 10, 2026 14.25 14.47 13.24 13.70 13.70 179,224
Jul 9, 2026 14.49 14.71 13.95 14.25 14.25 162,968
Jul 8, 2026 14.06 14.81 14.02 14.49 14.49 198,849
Jul 7, 2026 14.66 14.86 14.09 14.26 14.26 275,964
Jul 6, 2026 14.90 15.10 14.41 14.51 14.51 242,106
Jul 2, 2026 14.88 15.51 14.77 15.11 15.11 299,427
Jul 1, 2026 14.63 15.20 14.63 14.77 14.77 206,504
Jun 30, 2026 14.53 14.66 14.26 14.58 14.58 281,182
Jun 29, 2026 14.02 14.73 13.94 14.51 14.51 342,573
Jun 26, 2026 13.51 14.25 13.43 14.00 14.00 938,109
Jun 25, 2026 13.72 14.20 13.32 13.45 13.45 181,110
Jun 24, 2026 14.08 14.70 13.69 13.72 13.72 286,556
Jun 23, 2026 13.22 14.12 12.92 14.06 14.06 401,620
Jun 22, 2026 12.85 13.40 12.65 13.37 13.37 225,467
Jun 18, 2026 12.87 13.10 12.48 12.66 12.66 254,121
Jun 17, 2026 12.05 12.65 12.05 12.64 12.64 171,430
Jun 16, 2026 11.44 12.07 11.33 12.07 12.07 142,652
Jun 15, 2026 11.95 12.22 11.41 11.44 11.44 114,011
Jun 12, 2026 11.48 12.10 11.11 11.90 11.90 190,271
Jun 11, 2026 11.75 11.75 11.18 11.51 11.51 263,185
Jun 10, 2026 11.35 11.75 11.21 11.70 11.70 142,985
Jun 9, 2026 11.23 11.55 11.19 11.35 11.35 131,333
Jun 8, 2026 11.47 13.23 10.86 11.07 11.07 158,110
Jun 5, 2026 11.68 11.68 11.25 11.28 11.28 135,055
Jun 4, 2026 11.33 11.98 11.33 11.73 11.73 208,575
Jun 3, 2026 11.92 12.03 11.17 11.24 11.24 372,302
Jun 2, 2026 12.51 12.60 11.91 12.03 12.03 196,987
Jun 1, 2026 13.10 13.31 12.50 12.67 12.67 198,306
May 29, 2026 13.19 13.31 13.02 13.16 13.16 187,996
May 28, 2026 13.19 13.49 13.05 13.23 13.23 165,553
May 27, 2026 13.53 13.85 13.10 13.19 13.19 295,433
May 26, 2026 14.07 14.11 13.38 13.53 13.53 330,509
May 22, 2026 13.94 14.40 13.79 13.95 13.95 141,313
May 21, 2026 13.50 13.96 13.40 13.83 13.83 141,618
May 20, 2026 13.76 14.24 13.54 13.61 13.61 161,204
May 19, 2026 13.47 13.91 13.35 13.76 13.76 203,871
May 18, 2026 13.43 13.86 13.24 13.45 13.45 259,329
May 15, 2026 13.59 14.00 13.19 13.41 13.41 221,933
May 14, 2026 13.98 14.12 13.55 13.81 13.81 269,710
May 13, 2026 14.37 14.91 14.02 14.03 14.03 159,216
May 12, 2026 14.60 15.38 13.59 14.53 14.53 367,018
May 11, 2026 15.55 15.89 15.10 15.46 15.46 298,486
May 8, 2026 15.06 15.70 15.00 15.34 15.34 191,732
May 7, 2026 15.30 15.93 14.78 15.09 15.09 196,492
May 6, 2026 14.53 15.28 14.47 15.24 15.24 344,924
May 5, 2026 14.67 14.94 13.81 14.48 14.48 271,712
May 4, 2026 14.19 14.93 14.09 14.54 14.54 154,787
May 1, 2026 13.89 14.47 13.76 14.35 14.35 161,447
Apr 30, 2026 13.87 14.27 13.57 13.89 13.89 162,688
Apr 29, 2026 13.36 13.92 13.36 13.87 13.87 118,331
Apr 28, 2026 13.26 13.78 13.26 13.71 13.71 102,662
Apr 27, 2026 13.26 13.87 13.20 13.28 13.28 92,383
Apr 24, 2026 13.27 13.54 12.80 13.31 13.31 164,733
Apr 23, 2026 13.79 14.00 13.27 13.35 13.35 90,127
Apr 22, 2026 13.31 13.89 13.10 13.79 13.79 113,740
Apr 21, 2026 13.77 13.83 13.19 13.24 13.24 114,861
Apr 20, 2026 13.96 14.44 13.76 13.78 13.78 101,582
Apr 17, 2026 14.32 14.32 13.96 14.01 14.01 123,144
Apr 16, 2026 14.40 14.52 14.02 14.06 14.06 83,361
Apr 15, 2026 14.63 14.89 14.33 14.55 14.55 108,441
Apr 14, 2026 14.10 14.87 13.29 14.63 14.63 111,170
Apr 13, 2026 14.09 14.42 13.93 14.27 14.27 71,983
Apr 10, 2026 13.94 14.41 13.85 14.11 14.11 227,552
Apr 9, 2026 13.67 14.12 13.43 13.95 13.95 108,334
Apr 8, 2026 13.81 14.00 13.56 13.77 13.77 76,940
Apr 7, 2026 13.19 13.47 12.84 13.43 13.43 91,753
Apr 6, 2026 13.17 13.59 12.80 13.25 13.25 115,597
Apr 2, 2026 12.66 13.26 12.61 13.14 13.14 112,823
Apr 1, 2026 12.76 13.32 12.14 12.97 12.97 202,061
Mar 31, 2026 12.43 12.76 12.23 12.63 12.63 107,548
Mar 30, 2026 12.14 12.44 11.75 12.18 12.18 126,890
Mar 27, 2026 12.41 13.28 11.97 12.18 12.18 121,450
Mar 26, 2026 12.31 13.54 12.15 12.51 12.51 158,355
Mar 25, 2026 12.20 12.68 12.07 12.17 12.17 145,354
Mar 24, 2026 12.51 12.54 12.04 12.08 12.08 114,432
Mar 23, 2026 12.80 12.98 12.57 12.65 12.65 114,136
Mar 20, 2026 13.00 13.19 12.44 12.51 12.51 199,671
Mar 19, 2026 12.52 13.10 12.48 13.00 13.00 134,040
Mar 18, 2026 13.14 13.69 12.64 12.70 12.70 130,753
Mar 17, 2026 12.91 13.65 12.75 13.27 13.27 133,067
Mar 16, 2026 12.87 12.98 12.51 12.91 12.91 175,868
Mar 13, 2026 13.63 13.67 12.67 12.70 12.70 473,344
Mar 12, 2026 13.86 14.00 13.32 13.41 13.41 101,774
Mar 11, 2026 13.82 14.27 13.80 14.17 14.17 103,001
Mar 10, 2026 13.91 14.22 13.74 13.95 13.95 84,053
Mar 9, 2026 13.21 14.03 13.21 13.89 13.89 130,587
Mar 6, 2026 13.56 13.99 13.17 13.54 13.54 144,093
Mar 5, 2026 15.22 15.48 13.71 13.74 13.74 240,512
Mar 4, 2026 14.61 15.68 14.61 15.41 15.41 311,279
Mar 3, 2026 14.48 15.00 14.23 14.72 14.72 164,216
Mar 2, 2026 14.02 14.60 13.96 14.51 14.51 188,172
Feb 27, 2026 14.25 14.32 13.88 14.30 14.30 115,324
Feb 26, 2026 14.61 14.70 14.14 14.41 14.41 177,681
Feb 25, 2026 14.85 15.28 14.46 14.64 14.64 164,494
Feb 24, 2026 13.60 14.89 13.39 14.75 14.75 334,772
Feb 23, 2026 13.57 14.07 13.19 13.49 13.49 161,410
Feb 20, 2026 13.89 14.16 13.02 13.51 13.51 435,611
Feb 19, 2026 13.55 14.31 13.52 14.00 14.00 200,864
Feb 18, 2026 13.82 14.19 13.82 13.89 13.89 134,746
Feb 17, 2026 13.89 14.12 13.65 13.86 13.86 104,543
Feb 13, 2026 13.84 14.26 13.53 13.85 13.85 136,383
Feb 12, 2026 14.03 14.38 13.82 13.84 13.84 174,462
Feb 11, 2026 14.26 14.47 13.85 14.25 14.25 207,572
Feb 10, 2026 15.12 15.55 13.33 14.13 14.13 385,627
Feb 9, 2026 13.51 13.89 13.18 13.83 13.83 220,999
Feb 6, 2026 13.22 13.62 13.22 13.51 13.51 164,022
Feb 5, 2026 13.09 13.49 12.95 12.97 12.97 176,618
Feb 4, 2026 13.54 13.56 13.16 13.48 13.48 161,638
Feb 3, 2026 13.17 13.66 13.12 13.57 13.57 170,761
Feb 2, 2026 12.76 13.35 12.76 13.19 13.19 177,357
Jan 30, 2026 12.83 12.98 12.45 12.90 12.90 208,748
Jan 29, 2026 12.54 13.03 12.53 12.90 12.90 135,308
Jan 28, 2026 12.98 13.01 12.60 12.65 12.65 163,477
Jan 27, 2026 12.92 13.29 12.58 12.98 12.98 169,625
Jan 26, 2026 13.00 13.05 12.55 12.92 12.92 209,122
Jan 23, 2026 12.76 13.05 12.32 13.02 13.02 288,406
Jan 22, 2026 12.53 13.00 12.53 12.80 12.80 260,366
Jan 21, 2026 12.43 12.79 12.41 12.57 12.57 270,882
Jan 20, 2026 12.35 13.98 12.09 12.49 12.49 183,635
Jan 16, 2026 13.28 13.28 12.50 12.61 12.61 341,182
Jan 15, 2026 13.87 13.93 13.21 13.35 13.35 321,565
Jan 14, 2026 13.08 13.98 12.94 13.84 13.84 221,774
Jan 13, 2026 12.88 13.27 12.53 13.13 13.13 194,272
Jan 12, 2026 13.06 13.14 12.53 12.91 12.91 303,412
Jan 9, 2026 13.50 13.64 13.02 13.11 13.11 214,300
Jan 8, 2026 13.76 13.82 13.24 13.44 13.44 229,755
Jan 7, 2026 13.58 13.97 13.43 13.89 13.89 197,383
Jan 6, 2026 13.84 13.84 13.45 13.58 13.58 216,028
Jan 5, 2026 14.42 14.78 13.66 13.91 13.91 461,640
Jan 2, 2026 15.79 15.93 14.30 14.42 14.42 354,276
Dec 31, 2025 15.84 16.52 15.42 15.77 15.77 480,182
Dec 30, 2025 16.42 16.88 15.80 15.90 15.90 345,719
Dec 29, 2025 16.74 17.15 16.29 16.43 16.43 318,071
Dec 26, 2025 16.56 16.90 16.20 16.85 16.85 251,280
Dec 24, 2025 15.84 17.05 15.84 16.60 16.60 292,146
Dec 23, 2025 16.10 16.22 15.70 15.71 15.71 314,519
Dec 22, 2025 15.43 16.48 15.09 16.21 16.21 492,121
Dec 19, 2025 14.58 15.86 14.42 15.39 15.39 1,688,883
Dec 18, 2025 14.44 14.89 14.11 14.53 14.53 316,921
Dec 17, 2025 14.89 15.08 14.06 14.25 14.25 334,319
Dec 16, 2025 14.72 15.28 14.40 14.85 14.85 358,027
Dec 15, 2025 14.89 15.20 14.35 14.87 14.87 364,145
Dec 12, 2025 14.13 14.95 13.98 14.73 14.73 254,941
Dec 11, 2025 14.38 14.62 14.05 14.14 14.14 254,763
Dec 10, 2025 14.63 14.79 14.19 14.37 14.37 197,811
Dec 9, 2025 14.07 14.69 13.79 14.64 14.64 254,258
Dec 8, 2025 14.78 14.78 13.75 14.18 14.18 320,494
Dec 5, 2025 14.07 14.65 13.89 14.60 14.60 334,049
Dec 4, 2025 14.00 14.46 13.93 14.09 14.09 246,055
Dec 3, 2025 14.02 14.52 14.00 14.24 14.24 268,579
Dec 2, 2025 14.08 14.32 13.80 13.96 13.96 356,377
Dec 1, 2025 13.80 14.51 13.80 14.14 14.14 436,775
Nov 28, 2025 13.97 14.22 13.63 14.12 14.12 143,060
Nov 26, 2025 13.72 14.21 13.50 13.94 13.94 214,978
Nov 25, 2025 13.78 13.86 12.97 13.66 13.66 425,466
Nov 24, 2025 12.91 13.78 12.70 13.65 13.65 457,375
Nov 21, 2025 12.08 13.00 11.89 12.73 12.73 273,607
Nov 20, 2025 12.29 12.84 11.97 12.13 12.13 281,030
Nov 19, 2025 12.27 12.81 11.89 12.13 12.13 259,095
Nov 18, 2025 12.22 13.55 11.80 12.36 12.36 504,061
Nov 17, 2025 12.06 12.94 11.85 12.82 12.82 410,574
Nov 14, 2025 11.98 12.50 11.70 12.06 12.06 276,146
Nov 13, 2025 11.84 11.96 11.61 11.72 11.72 206,090
Nov 12, 2025 12.11 12.41 11.78 11.93 11.93 264,677
Nov 11, 2025 11.56 12.47 11.10 12.04 12.04 327,037
Nov 10, 2025 11.22 11.53 11.00 11.51 11.51 249,527
Nov 7, 2025 10.71 11.00 10.22 10.99 10.99 213,058
Nov 6, 2025 10.93 11.06 10.41 10.80 10.80 177,881
Nov 5, 2025 10.79 11.20 10.61 10.92 10.92 273,246
Nov 4, 2025 10.62 11.34 10.56 10.81 10.81 640,094
Nov 3, 2025 10.92 11.18 10.44 10.82 10.82 380,966
Oct 31, 2025 10.89 11.08 10.62 10.96 10.96 367,961
Oct 30, 2025 10.55 11.45 10.55 10.86 10.86 675,538
Oct 29, 2025 10.44 11.15 10.33 10.63 10.63 1,092,879
Oct 28, 2025 10.48 10.61 10.30 10.47 10.47 407,089
Oct 27, 2025 10.53 10.79 10.39 10.50 10.50 475,600
Oct 24, 2025 10.79 10.91 10.48 10.51 10.51 357,299
Oct 23, 2025 10.50 11.01 10.20 10.67 10.67 825,402
Oct 22, 2025 10.94 11.10 10.43 10.49 10.49 553,784
Oct 21, 2025 11.13 11.22 10.71 11.01 11.01 389,291
Oct 20, 2025 11.12 11.59 11.04 11.12 11.12 491,107
Oct 17, 2025 11.25 11.55 10.86 11.01 11.01 325,533
Oct 16, 2025 11.84 12.02 11.34 11.38 11.38 378,942
Oct 15, 2025 11.06 11.83 11.01 11.68 11.68 417,348
Oct 14, 2025 11.41 11.50 10.87 10.96 10.96 409,686
Oct 13, 2025 11.09 11.50 10.96 11.49 11.49 550,809
Oct 10, 2025 11.51 11.51 10.86 11.02 11.02 296,415
Oct 9, 2025 11.40 11.82 11.16 11.46 11.46 365,597
Oct 8, 2025 11.23 11.54 10.95 11.30 11.30 584,451
Oct 7, 2025 11.30 11.46 10.81 11.08 11.08 509,679
Oct 6, 2025 10.33 11.59 10.23 11.35 11.35 892,055
Oct 3, 2025 10.26 10.79 10.12 10.33 10.33 785,076
Oct 2, 2025 10.65 10.95 10.09 10.33 10.33 972,190
Oct 1, 2025 10.22 11.85 9.91 10.61 10.61 3,543,501
Sep 30, 2025 14.99 15.09 11.30 11.97 11.97 2,026,862
Sep 29, 2025 7.15 15.34 7.05 15.16 15.16 16,718,532
Sep 26, 2025 7.71 8.02 7.48 7.90 7.90 1,630,315
Sep 25, 2025 7.75 7.97 7.59 7.75 7.75 372,791
Sep 24, 2025 7.25 7.87 7.17 7.81 7.81 498,257

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Enanta Pharmaceuticals, Inc Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ENTA, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation